AEMD - エスロン・メディカル （Aethlon Medical Inc.） エスロン・メディカルAEMDのチャート
AEMDの企業情報
| symbol | AEMD |
|---|---|
| 会社名 | Aethlon Medical Inc （エスロン・メディカル） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 Aethlon Medical Inc. is a medical device company focused on creating devices for cancer infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon which represents its therapeutic business activities and ESI which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications the Hemopurifier targets the removal of circulating exosomes which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary Exosome Sciences Inc. (Exosome) the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer. エスロン・メディカルは米国の医療機器メ―カ―。がんや感染症疾患治療用ろ過装置の開発、製造に従事する。同社の「エスロン・キ―モピュ―リファイア」はHIVやC型肝炎ウイルスなどのウイルス性病原体治療用血液浄化フィルタ―で、患者の血液や腹水からエキソソ―ムを除去することが可能。また、乳がん用や敗血症用フィルタ―も扱う。本社はカリフォルニア州。 Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. |
| 本社所在地 | 9635 Granite Ridge Drive Suite 100 San Diego CA 92123 USA |
| 代表者氏名 | Rodney S. Kenley ロドニー・S・ケンリー |
| 代表者役職名 | President Director 社長 |
| 電話番号 | +1 858-459-7800 |
| 設立年月日 | 33329 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 6人 |
| url | www.aethlonmedical.com |
| nasdaq_url | https://www.nasdaq.com/symbol/aemd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -4.73369 |
| 終値（lastsale） | 1.07 |
| 時価総額（marketcap） | 19044125.36 |
| 時価総額 | 時価総額（百万ドル） 19.75606 |
| 売上高 | 売上高（百万ドル） 0.29925 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 14.50460 |
| 当期純利益 | 当期純利益（百万ドル） -4.98401 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 30 June 2018 Aethlon Medical Inc. revenues increased from $0K to $150K. Net loss decreased 38% to $1.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Loss on debt extinguishment decrease from $377K (expense) to $0K Amortization of Note Discounts decrease of 80% to $30K (expense). |
AEMDのテクニカル分析
AEMDのニュース
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/04/20 17:33:20 Benzinga
Gainers Aditxt, Inc. (NASDAQ: ADTX ) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market broad-spectrum antiviral drug Avigan. Augmedix, Inc. (NASDAQ: AUGX ) shares rose 64% to $2.96 after the company announced a partnership with HCA Healthcare to accelerate the development of AI-enabled ambient documentation. Aethlon Medical, Inc. (NASDAQ: AEMD ) gained 64% to $0.69. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP ) rose 53% to $2.72. Getaround, Inc. (NYSE: GETR ) surged 38% to $0.4955 after jumping over 40% on Wednesday. Getaround recently said it sees preliminary FY22 total revenues of $59 million to $60 million. United Insurance Holdings Corp. (NASDAQ: UIHC ) gained 30.9% to $2.16. United Insurance said unit entered memorandum with Florida Department of Financial Services, Division of Rehabilitation and Liquidation. ContraFect Corporation (NASDAQ: CFRX ) rose 23% to $2.17. Satixfy Communications Ltd. (NYSE: SATX ) climbed 21% to $1.05.
Aethlon Medical Inc. (NASDAQ: AEMD) Stock Forecast For 2023: $9.00 Per Share On The Upside 2023/02/20 20:00:00 Marketing Sentinel
In the last trading session, 0.2 million Aethlon Medical Inc. (NASDAQ:AEMD) shares changed hands as the company’s beta touched 1.23. With the company’s per share price at $0.54 changed hands at -$0.02 or -2.94% during last session, the market valuation stood at $12.80M. AEMD’s last price was a discount, traded about -355.56% off its 52-week … Aethlon Medical Inc. (NASDAQ: AEMD) Stock Forecast For 2023: $9.00 Per Share On The Upside Read More »
Aethlon Medical, Inc. (AEMD) Q3 2023 Earnings Call Transcript 2023/02/13 23:37:07 Seeking Alpha
Aethlon Medical, Inc. (NASDAQ:NASDAQ:AEMD) Q3 2023 Earnings Conference Call February 13, 2023 4:30 PM ETCompany ParticipantsJim Frakes - Chief Financial OfficerSteven LaRosa - Chief Medical…
Aethlon Medical GAAP EPS of -$0.12 misses by $0.04 2023/02/13 21:18:42 Seeking Alpha
Aethlon Medical press release (AEMD): Q3 GAAP EPS of -$0.12 misses by $0.04.As of December 31, 2022, Aethlon Medical had a cash balance of approximately $17.5 million.Aethlon did…
Preview: Aethlon Medical''s Earnings 2023/02/10 17:01:26 Benzinga
Aethlon Medical (NASDAQ: AEMD ) is set to give its latest quarterly earnings report on Monday, 2023-02-13. Here''s what investors need to know before the announcement. Analysts estimate that Aethlon Medical will report an earnings per share (EPS) of $-0.17. Aethlon Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com
Aethlon Medical, Inc. (AEMD) Q2 2022 Earnings Call Transcript 2022/11/14 23:18:03 Seeking Alpha
Aethlon Medical, Inc. (NASDAQ:NASDAQ:AEMD) Q2 2022 Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Charles Fisher - Chief Executive Officer James Frakes -…
Aethlon Medical GAAP EPS of -$0.18 2022/11/14 21:29:02 Seeking Alpha
Aethlon Medical press release (AEMD): Q2 GAAP EPS of -$0.18.As of September 30, 2022, Aethlon Medical had a cash balance of approximately $19.6 million.
Aethlon Medical Q3 2023 Earnings Preview 2022/11/13 22:35:18 Seeking Alpha
Aethlon Medical (AEMD) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.The consensus EPS Estimate is -$0.21 (-5.0% Y/Y) and the consensus…
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022 2022/11/02 18:43:00 PR Newswire
SAN DIEGO, Nov. 2, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second quarter ended September 30, 2022, at 4:15…
Aethlon Medical (AEMD) Investor Presentation - Slideshow 2022/09/19 14:39:36 Seeking Alpha
The following slide deck was published by Aethlon Medical, Inc.
$260,000.00 in Sales Expected for Aethlon Medical, Inc. (NASDAQ:AEMD) This Quarter 2021/11/29 00:04:41 Dakota Financial News
Wall Street analysts expect that Aethlon Medical, Inc. (NASDAQ:AEMD) will announce $260,000.00 in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Aethlon Medicals earnings. The highest sales estimate is $400,000.00 and the lowest is $110,000.00. Aethlon Medical reported sales of $630,000.00 in the same quarter last year, which []
Geode Capital Management LLC Grows Stock Position in Aethlon Medical, Inc. (NASDAQ:AEMD) 2021/11/27 09:06:43 Dakota Financial News
Geode Capital Management LLC boosted its stake in Aethlon Medical, Inc. (NASDAQ:AEMD) by 54.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 103,121 shares of the medical equipment providers stock after purchasing an additional 36,368 shares during the period. Geode Capital Management LLC owned about 0.67% of []
Analysts Expect Aethlon Medical, Inc. (NASDAQ:AEMD) to Post -$0.13 EPS 2021/11/26 23:52:41 Dakota Financial News
Equities analysts forecast that Aethlon Medical, Inc. (NASDAQ:AEMD) will post earnings of ($0.13) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Aethlon Medicals earnings. Aethlon Medical posted earnings of ($0.20) per share in the same quarter last year, which indicates a positive year over year []
Zacks: Brokerages Expect Aethlon Medical, Inc. (NASDAQ:AEMD) Will Announce Earnings of -$0.18 Per Share 2021/11/19 16:32:41 Dakota Financial News
Wall Street analysts expect that Aethlon Medical, Inc. (NASDAQ:AEMD) will post ($0.18) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Aethlon Medicals earnings. The lowest EPS estimate is ($0.22) and the highest is ($0.13). Aethlon Medical posted earnings per share of ($0.20) in the same quarter []
Aethlon Medical (NASDAQ:AEMD) Posts Earnings Results, Beats Expectations By $0.02 EPS 2021/11/11 21:30:41 Transcript Daily
Aethlon Medical (NASDAQ:AEMD) released its quarterly earnings data on Tuesday. The medical equipment provider reported ($0.13) EPS for the quarter, beating analysts consensus estimates of ($0.15) by $0.02, MarketWatch Earnings reports. During the same period in the prior year, the company posted ($0.15) earnings per share. Shares of Aethlon Medical stock traded up $0.07 during []